You're looking at your joint supplement section and wondering whether the bottom two SKUs are earning their shelf space.
Dr. Tim's just gave you the reason to pull the trigger
Dr. Tim's Pet Food relaunched Tri-FLEXA, the reformulated version of its Tri-COX TRP joint supplement. The updated formula removes fillers (no wheat, no corn, no maltodextrin, no animal by-products), slightly increases EPA and DHA omega-3 levels, and improves palatability. Developed by veterinarian Dr. Timothy Hunt, the product is now available through Dr. Tim's and participating retailers.
The company says the goal was to make an already effective supplement better by improving ingredient quality and making it more enjoyable for dogs to eat.
The decision this creates
You already carry multiple joint SKUs. The question isn't whether Tri-FLEXA is a good product, the question is whether it's a better use of shelf space than what's sitting there now with slow velocity.
Here's the play: Pull your last 12 months of joint supplement sales by SKU. Rank them by dollar velocity, not units. Anything in the bottom third that doesn't have a specific customer asking for it by name is a candidate to swap out. A reformulation like this one is the permission structure to make that call without the rep claiming you didn't give the line a fair shot.
If Dr. Tim's has an existing relationship with your store through their food line, that's the angle: one fewer vendor to manage. If they don't, the reformulation alone isn't enough to displace an incumbent unless palatability complaints are a real problem you're hearing at the counter.
More reads like this, free, weekly. subscribe to PetRetailNews.
What premium food brands are actually doing
Dr. Tim's isn't the first premium food brand to push deeper into supplements, and they won't be the last. Dr. Tim's has veterinary credibility, the company was founded by veterinarian Dr. Tim Hunt. The reformulation, cleaner ingredients, gluten-free, higher omega-3s, is what buyers expect from a premium supplement in this category.
The risk for you: if this works, expect similar moves from other food brands in your mix. Watch for supplement line extensions from brands that historically stayed in their lane. It changes the vendor conversation when the food rep is also pitching you consumable SKUs.
The failure mode
The failure mode is carrying this because the rep asked nicely and you didn't want to say no. The buyer picks based on what their vet mentioned, what a friend's dog responded to, or what the store owner recommended when their dog started limping. A new SKU without a story you can tell at the counter just sits.
If you bring this in, know the answer to: Why this one instead of the one that's been here for three years? The reformulation gives you that answer if the old formula had palatability issues or if cleaner ingredients is a thing your customers actually ask about. If neither is true, the answer is vendor consolidation or you're testing whether Dr. Tim's brand equity transfers from food to supplements. Both are fine reasons. "The rep brought samples" is not.
What being wrong costs
Being wrong costs shelf space and cash tied up in inventory that could've gone to a SKU you know moves. It also costs the customer interaction when they ask what's good for joint health and you recommend something you brought in last month that you haven't actually seen work yet.
The reframe: treat every reformulation announcement as a line review trigger, not a product launch. The news isn't that Dr. Tim's made Tri-FLEXA better. The news is that you now have a reason to look at your joint supplement velocity and make a call you've been putting off.